In this study, using a novel approach, we derived a new signature of Rb loss-of-function (RBsig) with the specific aim of testing whether this might help in discriminating between palbociclib resistant versus sensitive breast cancer cell lines. The gene discussed is RB1; the disease is breast carcinoma.